Novo Nordisk CEO to step down as Wegovy maker faces rising competitors
Novo Nordisk CEO Lars Jorgensen testifies earlier than a Senate Well being, Training, Labor, and Pensions Committee listening to on U.S. costs for the burden loss medicine Ozempic and Wegovy,…
